⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL285073 | 0.97 | — | — | |
| SCHEMBL18687 | 0.90 | — | — | |
| SCHEMBL674177 | 0.78 | ALDH1A1 (0.60) | — | |
| SCHEMBL3009 | 0.76 | — | — | |
| SCHEMBL567977 | 0.75 | ALDH1A1 (0.56) | — | |
| SCHEMBL175198 | 0.75 | — | — | |
| SCHEMBL566326 | 0.73 | ALDH1A1 (0.53) | — | |
| SCHEMBL675729 | 0.71 | ALDH1A1 (0.50) | — | |
| SCHEMBL235202 | 0.69 | — | — | |
| SCHEMBL7509079 | 0.69 | ALDH1A1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1386 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814698-B2 | Methods for simultaneous leaching and extraction of precious metals | EXCIR WORKS CORP. (CA) | 2023-11-14 | — | — | US | claimed |
| WO-2023151635-A1 | COMPOUND BASED ON QUINAZOLINE-SUBSTITUTED GLUTARIMIDE SKELETON AND USE THEREOF | 标新生物医药科技(上海)有限公司 | 2023-08-17 | — | — | WO | claimed |
| CN-116589445-A | Compound based on quinazoline substituted glutarimide skeleton and application thereof | 标新生物医药科技(上海)有限公司 | 2023-08-15 | — | — | CN | claimed |
| US-20220340998-A1 | METHODS FOR SIMULTANEOUS LEACHING AND EXTRACTION OF PRECIOUS METALS | EXCIR WORKS CORP. (CA) | 2022-10-27 | — | — | US | claimed |
| US-11427886-B2 | Methods for simultaneous leaching and extraction of precious metals | EXCIR WORKS CORP. (CA) | 2022-08-30 | — | — | US | claimed |
| CN-113969358-A | Method for selective leaching and extraction of precious metals in organic solvents | 艾克希尔工厂公司 | 2022-01-25 | — | — | CN | claimed |
| CN-108026608-B | Method for selective leaching and extraction of precious metals in organic solvents | 艾克希尔工厂公司 | 2021-10-22 | — | — | CN | claimed |
| EP-3770148-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | Beijing Tide Pharmaceutical Co., Ltd. (CN) | 2021-01-27 | — | — | EP | claimed |
| CN-111801318-A | Receptor inhibitors, pharmaceutical compositions comprising the same and uses thereof | 北京泰德制药股份有限公司 | 2020-10-20 | — | — | CN | claimed |
| WO-2019179515-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | 北京泰德制药股份有限公司 | 2019-09-26 | — | — | WO | claimed |
| EP-1218372-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | Boehringer Ingelheim Pharmaceuticals, Inc. (US) | 2002-07-03 | — | — | EP | claimed |
| US-20020058809-A1 | Compounds useful as reversible inhibitors of cysteine proteases | EMMANUEL MICHEL JOSE (US) | 2002-05-16 | — | — | US | claimed |
| WO-2001019816-A1 | NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 2001-03-22 | — | — | WO | claimed |
| US-6100262-A | MORPHOLINE RING NITROGEN IS SUBSTITUTED WITH A GROUP HAIVNG A CARBONYL FUNCTIONALITY; FAVOURABLE GASTROINTESTINAL MOTILITY STIMULATING PROPERTIES, THEY ACCELERATE GASTRIC EMPTYING | JANSSEN PHARMACEUTICA, NV. (BE) | 2000-08-08 | — | — | US | claimed |
| US-5756730-A | Process for preparing analgesic compounds | SANKYO COMPANY, LIMITED (JP) | 1998-05-26 | — | — | US | claimed |
| EP-0827500-A1 | (2-MORPHOLINYLMETHYL)BENZAMIDE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-03-11 | — | — | EP | claimed |
| US-5656758-A | AMIDATION OF AN AMINE-CONTAINING THIOMORPHOLINE OR PIPERAZINE COMPOUND | SANKYO COMPANY, LIMITED (JP) | 1997-08-12 | — | — | US | claimed |
| WO-1996037486-A1 | (2-MORPHOLINYLMETHYL)BENZAMIDE DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1996-11-28 | — | — | WO | claimed |
| US-5025005-A | Preventive or therapeutic agents for circulatory diseases, allergic disorders; antineoplastic agent; inhibitor for platelet activating factor | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1991-06-18 | — | — | US | claimed |
| US-4737518-A | ANTIALLERGENS, ANTINEOPLASTICS, ANTICOAGULANTS, CIRCULATORY DISEASES | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1988-04-12 | — | — | US | claimed |